Wow.
The cult are a bit triggered by Novartis. I mean, forget the Covid trial which was halted early by the FDA. And please forget Msb have not progressed the Covid application for about two years. MSBs much promised update which was meant to occur by the end of last year still hasn’t happened.
Yup, that’s right … the Covid miracle cure which would be a financial bonanza if it actually works has been forgotten by msb.
The upside though, was it allowed msb to raise a bucket load of capital by spruking it. Maybe they’ll get to keep some from the class action plaintiffs?
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection, page-246
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
0.020(2.11%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 94.5¢ | 98.0¢ | 93.5¢ | $3.680M | 3.810M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 149921 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 60000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |